Literature DB >> 32519959

Can family physicians have a role in eradication of hepatitis c infection?

Ahmet Rıza Şahin1, Ayşegül Erdoğan2, Kadir Gisi3, Murat İspiroğlu3, Selma Ateş1, Ramazan Azim Okyay2, Selçuk Nazik1, Bülent Kantarçeken3.   

Abstract

BACKGROUND/AIMS: Hepatitis C Virus (HCV) infection is an important global public health problem. The application of screening programs is important for the elimination of HCV in addition to DAA therapies. The aim of this study was to measure the knowledge, attitudes and behaviours of family physicians, who are important in screening programs for the diagnosis, natural history, and treatment of HCV infection.
MATERIALS AND METHODS: This cross-sectional study aimed to measure the knowledge levels in respect of HCV screening, diagnosis, natural history and treatment, of family physicians working nationwide in Turkey, through a survey.
RESULTS: The most common reason to perform an anti-HCV test stated by 70.9% (n:420) of the participants was the mandatory screening program before marriage. Of the participants included in the study, 29.6% (n=175) had encountered anti-HCV test positivity at least once within the last year, and of these, 15.4% (n=27) had no knowledge of whether the patient went to a higher level center for further diagnosis, while 58.9% (n=103) did not know the disease stage. In response to questions about current drug options for hepatitis C infection, 14.5% were aware of DAA and 34.8% of participitant reported interferon+ ribavirin.
CONCLUSION: Family physicians have gaps in their knowledge of the screening, natural history and treatment of HCV infection. The results of this study show that HCV training plans for family physicians should cover all aspects of the infection, and emphasize the necessity for the establishment of guideline-based screening recommendations.

Entities:  

Year:  2020        PMID: 32519959      PMCID: PMC7289162          DOI: 10.5152/tjg.2020.19913

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  18 in total

Review 1.  A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease?

Authors:  Susan L Zickmund; Kyle E Brown; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Management of hepatitis C patients by primary care physicians in the USA: results of a national survey.

Authors:  T M Shehab; S S Sonnad; A S Lok
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

3.  A survey of Australian general practice management of hepatitis C-infected patients from non-English-speaking backgrounds.

Authors:  Anouk Dev; William Sievert
Journal:  J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 4.029

4.  Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.

Authors:  Anne C Moorman; Stuart C Gordon; Loralee B Rupp; Philip R Spradling; Eyasu H Teshale; Mei Lu; David R Nerenz; Cynthia C Nakasato; Joseph A Boscarino; Emily M Henkle; Nancy J Oja-Tebbe; Jian Xing; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

5.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

6.  Hepatitis C identification and management by family physicians.

Authors:  Elizabeth C Clark; Barbara P Yawn; James M Galliher; Jonathan L Temte; John Hickner
Journal:  Fam Med       Date:  2005-10       Impact factor: 1.756

7.  Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study.

Authors:  N Tozun; O Ozdogan; Y Cakaloglu; R Idilman; Z Karasu; U Akarca; S Kaymakoglu; O Ergonul
Journal:  Clin Microbiol Infect       Date:  2015-07-08       Impact factor: 8.067

Review 8.  Global epidemiology and genotype distribution of the hepatitis C virus infection.

Authors:  Erin Gower; Chris Estes; Sarah Blach; Kathryn Razavi-Shearer; Homie Razavi
Journal:  J Hepatol       Date:  2014-07-30       Impact factor: 25.083

9.  Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

10.  Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era.

Authors:  O Falade-Nwulia; A McAdams-Mahmoud; R Irvin; A Niculescu; K R Page; M Mix; D L Thomas; M S Sulkowski; S H Mehta
Journal:  J Community Med Health Educ       Date:  2016-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.